SCHEMBL20127640

SCHEMBL20127640

c1ccc2cc3c(ccc4c(-c5c6ccccc6c(-c6c7oc8ccccc8c7cc7c6oc6ccccc67)c6ccccc56)cccc43)cc2c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 2/20 0.38
SOS1 Q07889 1/20 0.36
AHR P35869 3/20 0.36
ALDH1A1 P00352 3/20 0.35
HSD17B10 Q99714 2/20 0.35
HIF1A Q16665 1/20 0.35
CYP1B1 Q16678 1/20 0.35
CYP1A2 P05177 3/20 0.35
HPGD P15428 2/20 0.35
NPC1 O15118 1/20 0.34
CYP2C9 P11712 1/20 0.34
CYP2C19 P33261 1/20 0.34
RAB9A P51151 1/20 0.34
ERBB2 P04626 1/20 0.33
FYN P06241 1/20 0.33
MAOA P21397 1/20 0.33
ACHE P22303 1/20 0.33
CES1 P23141 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20127446 0.95 SOS1 (0.39) ALOX5SOS1AHRALDH1A1HSD17B10
SCHEMBL20127637 0.91 ALOX5 (0.40) ALOX5SOS1AHRALDH1A1HSD17B10
SCHEMBL20412629 0.90 ALOX5 (0.41) ALOX5SOS1AHRALDH1A1HSD17B10
SCHEMBL20127439 0.88 SOS1 (0.46) ALOX5SOS1AHRALDH1A1HSD17B10
SCHEMBL22706979 0.86 ALOX5 (0.43) ALOX5SOS1AHRALDH1A1HSD17B10
SCHEMBL20127670 0.86 SOS1 (0.37) ALOX5SOS1AHRALDH1A1HSD17B10
SCHEMBL10122340 0.86 ALOX5 (0.43) ALOX5AHRALDH1A1HSD17B10HPGD
SCHEMBL19081453 0.84 ALOX5 (0.41) ALOX5AHRALDH1A1HSD17B10CYP1B1
SCHEMBL10122563 0.83 ALOX5 (0.41) ALOX5SOS1AHRALDH1A1HSD17B10
SCHEMBL10122338 0.83 AHR (0.41) ALOX5SOS1AHRALDH1A1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180208836-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2018-07-26 US disclosed
US-20180208836-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2018-07-26 US disclosed
US-20180130968-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2018-05-10 US disclosed
US-20180130968-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2018-05-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180130968-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE RER1, NR0B1, NR2E1 ALOX5 4115/4885SOS1 960/4885AHR 2558/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.